Why this trial matters: Provides real-world evidence on first-line regimens in a poor-prognosis mCRC subtype Highlights superior survival with chemo + anti-VEGF versus chemo alone or targeted therapy Reinforces the importance of personalized treatment strategies and further trials Eli Lilly Retatrutide Delivers Unprecedented Weight Loss in Phase III TRIUMPH-4 Trial Eli Lillys investigational triple-agonist retatrutide produced an average ~28.7% body-weight reduction (71.2 lbs) at 68 weeks in the Phase III TRIUMPH-4 obesity trial, along with meaningful knee osteoarthritis pain relief, marking one of the strongest weight-loss results reported in late-stage obesity research
However, the authors noted that few studies have tested microneedling as a standalone treatment most combine it with topicals
This infusion is provided only after an individual consultation, is not a treatment for any medical condition
Incorporating cruciferous vegetables like broccoli, Brussels sprouts, cauliflower, and kale can provide the raw materials your liver needs
While they are often grouped together under the umbrella of growth hormone peptides, each works through a distinct mechanism and serves a very different clinical purpose